Yüklüyor......
MET Receptor Tyrosine Kinase
MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor (HGF) have become important therapeutic target in oncology, especially lung cancer. MET RTK is involved in cancer cell growth/survival, motility/migration, invasion/metastasis, and in angiogenesis. MET can be overexpressed in...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2846396/ https://ncbi.nlm.nih.gov/pubmed/19861919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JTO.0000361752.86918.09 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|